Prescription and Non-Prescription Drug Classification Systems Across Countries: Lessons Learned for Thailand

References

• Sukrod N. Principle of Thailand medicine reclassification guidelines; 2015 Available from: http://www.tsmia.or.th/RTD2015/5-THAILAND%20(Sept%2017)%20Drug%20reclassification%20guideline%20(final).pdf. Accessed 423, 2020.
   Google Scholar
• Consumer Healthcare Product Association. Rx-to-OTC switch; 2019 Available from: https://www.chpa.org/switch.aspx. Accessed 1023, 2019.
   Google Scholar
• GOV.UK. Oral diclofenac presentations with legal status ‘P’ – reclassified to POM; 2015 Available from: https://www.gov.uk/drug-device-alerts/drug-alert-oral-diclofenac-presentations-with-legal-status-p-reclassified-to-pom. Accessed 1023, 2019.
   Google Scholar
• Consumer Healthcare Product Association. Rx-to-OTC switch: switch list; 2018 Available from: https://www.chpa.org/Switch.aspx. Accessed 1026, 2019.
   Google Scholar
• World Bank Group President Jim Yong Kim. Speech by World bank group president Jim Yong Kim on universal health coverage in emerging economies; 2014 Available from: https://www.worldbank.org/en/news/speech/2014/01/14/speech-world-bank-group-president-jim-yong-kim-health-emerging-economies. Accessed 82, 2020.
   Google Scholar
• Sakulbumrunsul R, Taychakhoonavudh S. Pricing and patient access framework to support universal coverage in Thailand. Available from: http://www.pharm.chula.ac.th/dept5/source/images/data/files/NHSO_PPA_Report_240317(2).pdf. Accessed 1217, 2020.
   Google Scholar
• Strategy and planning division: Office of the Permanent Secretary for Ministry of Public Health. Number of hospitals by category in Thailand; 2014 Available from: http://203.157.10.8/hcode_2014/query_02.php?p=3%20/. Accessed 412, 2020.
   Google Scholar
• Thai Food and Drug Administration. Number of pharmacies; 2017 Available from: http://www.fda.moph.go.th/sites/drug/Shared%20Documents/Statistic/establishment.pdf. Accessed 423, 2020.
   Google Scholar
• Saramunee K, Chaiyasong S, Krska J. Public health roles for community pharmacy: contrasts and similarities between England and Thailand. Isan J Pharm Sci. 2011;7(2):1–11.
   Google Scholar
• Thai Food and Drug Administration. Designation of number of type 2 community pharmacies; 2005 Available from: http://www.ratchakitcha.soc.go.th/DATA/PDF/2548/00155157.PDF?fbclid=IwAR2Qksp4wyeb5ZnkhGZXUNyigAjknzu92GMReDzdSdIfZGWjd6E32VwRwwE. Accessed 423, 2020.
   Google Scholar
• Thai Food and Drug Administration. Guideline of drug reclassification; 2016 Available from: http://www.fda.moph.go.th/sites/drug/Shared%20Documents/reclass/%E0%B8%A0%E0%B8%B2%E0%B8%84%E0%B8%9C%E0%B8%99%E0%B8%A7%E0%B8%81%20%E0%B8%84.pdf. Accessed 1023, 2019.
   Google Scholar
• The drug act (No. 6) B.E. 2562 (A.D. 2019). Available from: https://sme.go.th/upload/mod_download/download-20190508065825.PDF. Accessed 1218, 2019.
   Google Scholar
• World Health Organization. Thailand pharmaceutical profile; 2017 Available from: https://apps.who.int/iris/bitstream/handle/10665/274873/2017-Thailand-pharm-profile.pdf?sequence=1&isAllowed=y. Accessed 423, 2020.
   Google Scholar
• Chan RC, Ching PL. Pharmacy practice in Thailand. Am J Health Syst Pharm. 2005;62(13):1408–1411. doi:10.2146/ajhp04039315972385
   PubMed Web of Science ®Google Scholar
• Sriviriyanupap W. Developing indicators and method of drug classification according to Thai law. Thai J Pharm Sci. 2016;40.
   Google Scholar
• MGR Online. The propose of new drug classification scheme; 2018 Available from: https://mgronline.com/qol/detail/9610000088655. Accessed 1025, 2019.
   Google Scholar
• Sumpradit N, Chongtrakul P, Anuwong K, et al. Antibiotics smart use: a workable model for promoting the rational use of medicines in Thailand. Bull World Health Organ. 2012;90(12):905–913. doi:10.2471/BLT.12.10544523284196
   PubMed Web of Science ®Google Scholar
• Bangkok Post. Teens taking ‘taxi’ ride to drug addiction; 2018 Available from: https://www.bangkokpost.com/thailand/special-reports/1529006/teens-taking-taxi-ride-to-drug-addiction. Accessed 423, 2020.
   Google Scholar
• Thai Food and Drug Administration. Counterfeit drug manufacturing was found; 2018 Available from: http://pca.fda.moph.go.th/public_media_detail.php?id=2&cat=50&content_id=1671. Accessed 425, 2020.
   Google Scholar
• Thai Food and Drug Administration. Risks of 4x100 (pro drug); 2020 Available from: https://oryor.com/oryor_miniweb/knowledge_detail.php?cat=2&id=7. Accessed 423, 2020.
   Google Scholar
• Thai Food and Drug Administration. Drug database; 2019 Available from: http://pertento.fda.moph.go.th/FDA_SEARCH_DRUG/SEARCH_DRUG/FRM_SEARCH_DRUG.aspx. Accessed 114, 2019.
   Google Scholar
• GOV.UK. Medicines: reclassify your product; 2019 Available from: https://www.gov.uk/guidance/medicines-reclassify-your-product#classifications-of-medicines. Accessed 1023, 2019.
   Google Scholar
• Homhuan A. Amendments to Thailand’s drug act; 2019 Available from: https://www.tilleke.com/resources/amendments-thailand%E2%80%99s-drug-act. Accessed 82, 2020.
   Google Scholar
• Nomura K, Kitagawa Y, Yuda Y, Takano-Ohmuro H. Medicine reclassification processes and regulations for proper use of over-the-counter self-care medicines in Japan. Risk Manag Healthc Policy. 2016;9:173. doi:10.2147/RMHP.S9809927555801
   PubMed Web of Science ®Google Scholar
• Gauld NJ, Kelly FS, Emmerton LM, Buetow SA. Widening consumer access to medicines: a comparison of prescription to non-prescription medicine switch in Australia and New Zealand. PLoS One. 2015;10(3):e0119011. doi:10.1371/journal.pone.011901125785589
   PubMed Web of Science ®Google Scholar
• Gauld NJ, Kelly FS, Kurosawa N, Bryant LJ, Emmerton LM, Buetow SA. Widening consumer access to medicines through switching medicines to non-prescription: a six country comparison. PLoS One. 2014;9(9):e107726. doi:10.1371/journal.pone.010772625251434
   PubMed Web of Science ®Google Scholar
• World Health Organization. Proposal for updating the definition of stringent regulatory authority; 2017 Available from: https://www.who.int/medicines/areas/quality_safety/quality_assurance/SRA_QAS17-728Rev1_31082017.pdf?ua=1. Accessed 1026, 2019.
   Google Scholar
• The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Members & observers; 2019 Available from: https://www.ich.org/page/members-observers. Accessed 1026, 2019.
   Google Scholar
• Association of Southeast Asian Nations. ASEAN member states; 2019 Available from: https://asean.org/asean/asean-member-states/. Accessed 1210, 2019.
   Google Scholar
• Filmer D, Rogers H, Angrist N, Sabarwal S. Learning-Adjusted Years of Schooling (LAYS): Defining a New Macro Measure of Education. The World Bank; 2018.
   Google Scholar
• Human development index (HDI) by country; 2019 Available from: http://worldpopulationreview.com/countries/hdi-by-country/. Accessed 112, 2020.
   Google Scholar
• United Nations Development Programme. Global human development indicators; 2020 Available from: http://hdr.undp.org/en/countries/profiles/. Accessed 425, 2020.
   Google Scholar
• The World Bank. Education Statistics. 2019 Available from: https://databank.worldbank.org/indicator/UIS.SAP.CE?id=c755d342&report_name=EdStats_Indicators_Report&populartype=series. Accessed 112, 2020.
   Google Scholar
• World Health Organization. Density of physicians. Available from: https://www.who.int/gho/health_workforce/physicians_density/en/. Accessed 425, 2020.
   Google Scholar
• World Health Organization. Pharmacists (per 10,000 populations). Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/pharmacists-(per-10-000-population). Accessed 425, 2020.
   Google Scholar
• Collins S. A tale of two countries: the path to pharmacist prescribing in the United Kingdom and Canada; 2014 Available from: https://www.pharmacist.com/article/tale-two-countries-path-pharmacist-prescribing-united-kingdom-and-canada. Accessed 112, 2020.
   Google Scholar
• Deloitte Access Economics. Remuneration and regulation of community pharmacy; 2016 Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/4E0B6EEE19F56A40CA2581470016D688/$File/deloitte-community-pharmacy-literature-review-2016.pdf. Accessed 112, 2020.
   Google Scholar
• Nakagawa S, Kume N. Pharmacy practice in Japan. Can J Hosp Pharm. 2017;70(3):232. doi:10.4212/cjhp.v70i3.166328680178
   PubMedGoogle Scholar
• Competency standards for Singapore pharmacists; 2010 Available from: https://www.healthprofessionals.gov.sg/docs/librariesprovider3/forms-publications/competency-standards-for-singapore-pharmacists-(march-2010).pdf. Accessed 1113, 2020.
   Google Scholar
• Chau A. Are pharmacists’ roles as primary health professionals underutilised in Singapore? 2016 Available from: https://today.mims.com/are-pharmacists’roles-as-primary-health-professionals-underutilised-in-singapore-?channel=GN-Local-News-SG. Accessed 112, 2020.
   Google Scholar
• General Pharmaceutical Council. What does a pharmacist do? 2019 Available from: https://www.pharmacyregulation.org/raising-concerns/raising-concerns-about-pharmacy-professional/what-expect-your-pharmacy/what-does-0. Accessed 112, 2020.
   Google Scholar
• Albanese NP, Rouse MJ, Schlaifer M. Pharmacy CoCi. Scope of contemporary pharmacy practice: roles, responsibilities, and functions of pharmacists and pharmacy technicians. J Am Pharm Assoc. 2010;50(2):e35–e69. doi:10.1331/JAPhA.2010.10510
   Google Scholar
• Poisons act 1952 and regulations; 2019 Available from: http://www.agc.gov.my/agcportal/uploads/files/Publications/LOM/EN/Act%20366%20online.pdf. Accessed 112, 2020.
   Google Scholar
• Annuar A. Counter-productive’ for pharmacists to administer vaccines, doctors’ body says; 2019 Available from: https://www.malaymail.com/news/malaysia/2019/02/25/counter-productive-for-pharmacists-to-administer-vaccines-doctors-body-says/1726723. Accessed 112, 2020.
   Google Scholar
• Philippine Pharmacy Act. 2015 Available from: https://www.lawphil.net/statutes/repacts/ra2016/ra_10918_2016.html. Accessed 112, 2020.
   Google Scholar
• International Pharmaceutical Federation. An overview of current pharmacy impact on immunisation; 2016 Available from: https://www.fip.org/www/streamfile.php?filename=fip/publications/FIP_report_on_Immunisation.pdf. Accessed 112, 2020.
   Google Scholar
• Pharmaceutical Profession Act (No.2). 2015 Available from: https://library2.parliament.go.th/giventake/content_nla2557/law21-260358-69.pdf. Accessed 112, 2020.
   Google Scholar
• U.S. Food and Drug Administration. Prescription drug advertising; 2019 Available from: https://www.fda.gov/drugs/drug-information-consumers/prescription-drug-advertising. Accessed 425, 2020.
   Google Scholar
• GOV.UK. Advertise your medicines; 2020 Available from: https://www.gov.uk/guidance/advertise-your-medicines#advertise-to-the-public. Accessed 425, 2020.
   Google Scholar
• Graham JS, Swanson R. Distribution and marketing of drugs in Canada: overview; 2018 Available from: https://ca.practicallaw.thomsonreuters.com/0-618-6695?transitionType=Default&contextData=(sc.Default)&firstPage=true&bhcp=1. Accessed 425, 2020.
   Google Scholar
• Government of Canada. Health products advertising on physician web sites – questions and answers; 2011 Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/regulatory-requirements-advertising/policies-guidance-documents/health-products-advertising-physician-questions-answers.html. Accessed 425, 2020.
   Google Scholar
• Health Sciences Authority. Advertisements and promotions of therapeutic products; 2019 Available from: https://www.hsa.gov.sg/therapeutic-products/advertisements. Accessed 425, 2020.
   Google Scholar
• The international comparative legal guide to: pharmaceutical advertising; 2016 Available from: https://www.jurists.co.jp/sites/default/files/tractate_pdf/en/PA16_Japan.pdf. Accessed 425, 2020.
   Google Scholar
• Thai Food and Drug Administration. Things to know for drug advertisements; 2020 Available from: http://www.fda.moph.go.th/sites/drug/SitePages/advertisement03.aspx. Accessed 425, 2020.
   Google Scholar
• Baker M. Promoting medical products globally; 2018 Available from: https://www.bakermckenzie.com/-/media/files/insight/publications/2018/03/healthcare/ap/promoting-medical-products-globally_malaysia.pdf?la=en. Accessed 425, 2020.
   Google Scholar
• The ministry of health in collaboration with the World Health Organization. Philippines pharmaceutical country profile; 2011 Available from: https://www.who.int/medicines/areas/coordination/Philippines_PSCPBNarrativeQuestionnaireEndorsement_13062012.pdf?ua=1. Accessed 425, 2020.
   Google Scholar
• The food, drug, and cosmetic act, code of federal regulations. 2019.
   Google Scholar
• Medicines act 1968. 2020.
   Google Scholar
• Japan Pharmaceutical Manufacturers Association. Pharmaceutical administration and regulations in Japan; 2019 Available from: http://www.jpma.or.jp/english/parj/pdf/2019.pdf. Accessed 112, 2020.
   Google Scholar
• Health Products Act. 2016 Available from: https://sso.agc.gov.sg/SL/HPA2007-S329-2016. Accessed 112, 2020.
   Google Scholar
• National Association of Pharmacy Regulatory Authorities. Drug scheduling in Canada – general overview; 2019 Available from: https://napra.ca/drug-scheduling-canada-general-overview. Accessed 1210, 2019.
   Google Scholar
• U.S. Food and Drug Administration. How to buy medicines safely from an online pharmacy; 2018 Available from: https://www.fda.gov/consumers/consumer-updates/how-buy-medicines-safely-online-pharmacy. Accessed 425, 2020.
   Google Scholar
• GOV.UK. Register for the distance selling logo; 2017 Available from: https://www.gov.uk/guidance/register-for-the-distance-selling-logo. Accessed 425, 2020.
   Google Scholar
• Ministry of Health Malaysia. Tips on how to buy medicines online; 2020 Available from: https://www.pharmacy.gov.my/v2/en/content/tips-how-buy-medicines-online.html. Accessed 425, 2020.
   Google Scholar
• Government of Canada. Choosing a safe online pharmacy; 2020 Available from: https://www.canada.ca/en/health-canada/topics/buying-using-drug-health-products-safely/safe-use-online-pharmacies.html. Accessed 425, 2020.
   Google Scholar
• Faculty of Medicine Ramathibodi Hospital. Online drug sale; 2018 Available from: https://med.mahidol.ac.th/ramapharmacy/th/knowledge/general/05192016-1800-th. Accessed 220, 2020.
   Google Scholar
• Health Sciences Authority. Explanation note for application of a pharmacy licence; 2016 Available from: https://www.hsa.gov.sg/docs/default-source/hprg-ald/phl_explanation-noteb201f748dd3a4a8ca9bd36f432a3fded.pdf. Accessed 425, 2020.
   Google Scholar
• Consumer Healthcare Product Association. FAQs about drug distribution in the United States; 2019 Available from: https://www.chpa.org/FAQDrugDistribution.aspx. Accessed 1023, 2019.
   Google Scholar
• U.S. Food and Drug Administration. Legal requirements for the sale and purchase of drug products containing pseudoephedrine, ephedrine, and phenylpropanolamine; 2017 Available from: https://www.fda.gov/drugs/information-drug-class/legal-requirements-sale-and-purchase-drug-products-containing-pseudoephedrine-ephedrine-and. Accessed 112, 2020.
   Google Scholar
• National Association of Pharmacy Regulatory Authorities. Implementation of the national drug schedules; 2019 Available from: https://napra.ca/implementation-national-drug-schedules. Accessed 112, 2020.
   Google Scholar
• Comprehensive Dangerous Drugs Act. 2002 Available from: https://www.ddb.gov.ph/images/Board_Regulation/2014/BD.REG1.14.pdf. Accessed 112, 2020.
   Google Scholar
• Gauld N, Bryant L, Emmerton L, Kelly F, Kurosawa N, Buetow S. Why does increasing public access to medicines differ between countries? Qualitative comparison of nine countries. J Health Serv Res Policy. 2015;20(4):231–239. doi:10.1177/135581961559330226152909
   PubMed Web of Science ®Google Scholar
• Hennebry S. When a 20 year patent term just isn’t enough: market and data exclusivity; 2018 Available from: https://fpapatents.com/resource?id=483. Accessed 425, 2020.
   Google Scholar
• Medicines and Healthcare products Regulatory Agency. How to change the legal classification of a medicine in the UK; 2006 Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/277307/Legal_classification_changes.pdf. Accessed 425, 2020.
   Google Scholar
• Agency for Care Effectiveness. Drug evaluation methods and process guide; 2018 Available from: http://www.ace-hta.gov.sg/public-data/our-process-and-methods/ACE%20methods%20and%20process%20guide%20for%20drug%20evaluation%20(5%20Feb%202018).pdf. Accessed 425, 2020.
   Google Scholar
• Gauld NJ. How and Why Do Developed Countries Vary in Reclassifying Medicines from Prescription to Non-Prescription? University of Auckland; 2013.
   Google Scholar
• Camargo. Rx-to-OTC switch: expanding to the US over-the-counter market; 2017 Available from: https://camargopharma.com/resources/blog/rx-to-otc-switch-expanding-to-the-us-over-the-counter-market. Accessed 425, 2020.
   Google Scholar
• Mithun Raja. B, Raghavendra Rao. K. Regulatory and clinical requirements for prescription to OTC switches in USA and India; 2013 Available from: https://www.complianceonline.com/articlefiles/Regulatory_Requirements_Prescription_to_OTC_Switches_USA_India.pdf. Accessed 112, 2020.
   Google Scholar
• U.S. Food and Drug Administration. Bringing an over-the-counter (OTC) drugs to market; 2020 Available from: https://www.accessdata.fda.gov/scripts/cder/training/OTC/topic2/topic2/da_01_02_0080.htm. Accessed 425, 2020.
   Google Scholar
• Health Sciences Authority. Therapeutic products guidance; 2019 Available from: https://www.hsa.gov.sg/docs/default-source/hprg/therapeutic-products/guidance-documents/guidance-on-therapeutic-product-registration-in-singapore_jan2019.pdf. Accessed 425, 2020.
   Google Scholar
• Tago S, Ueda A, Kudo R, Guesdon L. Distribution and marketing of drugs in Japan: overview; 2019 Available from: https://uk.practicallaw.thomsonreuters.com/5-618-3562?transitionType=Default&contextData=(sc.Default)&firstPage=true&comp=pluk&bhcp=1. Accessed 425, 2020.
   Google Scholar
• National Association of Pharmacy Regulatory Authorities. National drug scheduling factors; 2017 Available from: https://napra.ca/sites/default/files/documents/NDSAC_Scheduling_Factors_website_September2017.pdf. Accessed 112, 2020.
   Google Scholar
• Katsura H. The approval standards for OTC drugs in Japan; 2015 Available from: http://www.tsmia.or.th/RTD2015/2-Japan%202nd%20self-CARER%20(PMDA%20Ehidemi%20Katsura).pdf. Accessed 117, 2020.
   Google Scholar
• Bakah SA. Regulation of OTC medicines in Malaysia; 2017 Available from: https://www.tga.gov.au/sites/default/files/international-over-counter-otc-medicines-regulators-forum-2017-malaysia.pdf. Accessed 1113, 2020.
   Google Scholar
• Official Portal of Pharmaceutical Services Programme, Ministry of Health Malaysia. Application for poisons classification guideline under the poisons act 1952; 2013 Available from: https://www.pharmacy.gov.my/v2/sites/default/files/document-upload/garispanduan.pdf. Accessed 112, 2020.
   Google Scholar
• Policies and guidelines on over-the-counter (OTC) drug products; 2000 Available from: https://ww2.fda.gov.ph/attachments/article/16557/ao%2023c%202000.pdf. Accessed 112, 2020.
   Google Scholar
• Republic of the Philippines DoH, Food and Drug Administration. Application process and requirements for post-approval changes of pharmaceutical products; 2014 Available from: https://ww2.fda.gov.ph/attachments/article/148395/FC2014-008%20-%20Application%20Process%20and%20Requirments%20for%20Post-Approval%20Changes%20of%20Pharmaceutical%20Products.pdf. Accessed 425, 2020.
   Google Scholar
• Ministry of Public Health. 30th notification of dangerous drugs; 2018 Available from: http://www.fda.moph.go.th/sites/drug/Shared%20Documents/Law03-TheMinistryOfHealth/Dangerousdrugs(30).PDF. Accessed 82, 2020.
   Google Scholar
• Ministry of Public Health. 53th notification of specially controlled drugs; 2019 Available from: http://www.fda.moph.go.th/sites/drug/Shared%20Documents/Law03-TheMinistryOfHealth/SPC(53).pdf. Accessed 82, 2020.
   Google Scholar